BIOMAT Database Logo BIOMAT Database Logo

[HHV-8 negative primary effusion lymphoma in a HIV negative patient]. 2003

Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
Department of Internal Medicine, Miyazaki Prefectural Hospital, Miyazaki.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006566 Herpesviridae Infections Virus diseases caused by the HERPESVIRIDAE. Herpesvirus Infections,B Virus Infection,Infections, Herpesviridae,Infections, Herpesvirus,B Virus Infections,Herpesviridae Infection,Herpesvirus Infection,Infection, B Virus,Infection, Herpesviridae,Infection, Herpesvirus,Infections, B Virus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D016393 Lymphoma, B-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. B-Cell Lymphoma,B Cell Lymphoma,B-Cell Lymphomas,Lymphoma, B Cell,Lymphomas, B-Cell
D016403 Lymphoma, Large B-Cell, Diffuse Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. Diffuse Large B-Cell Lymphoma,Diffuse, Large B-Cell, Lymphoma,Histiocytic Lymphoma, Diffuse,Lymphoma, Histiocytic, Diffuse,Diffuse Large-Cell Lymphoma,Histiocytic Lymphoma,Large Lymphoid Lymphoma, Diffuse,Large-Cell Lymphoma, Diffuse,Lymphoma, Diffuse Large-Cell,Lymphoma, Histiocytic,Lymphoma, Large Cell, Diffuse,Lymphoma, Large Lymphoid, Diffuse,Lymphoma, Large-Cell, Diffuse,Diffuse Histiocytic Lymphoma,Diffuse Histiocytic Lymphomas,Diffuse Large B Cell Lymphoma,Diffuse Large Cell Lymphoma,Diffuse Large-Cell Lymphomas,Histiocytic Lymphomas,Large Cell Lymphoma, Diffuse,Lymphoma, Diffuse Histiocytic,Lymphoma, Diffuse Large Cell
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal
D018023 HIV Seronegativity Immune status consisting of non-production of HIV antibodies, as determined by various serological tests. HTLV-III Seronegativity,HIV Seronegativities,HTLV III Seronegativity,HTLV-III Seronegativities,Seronegativities, HIV,Seronegativities, HTLV-III,Seronegativity, HIV,Seronegativity, HTLV-III
D019288 Herpesvirus 8, Human A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and "classical" Kaposi sarcoma. Herpesvirus, Kaposi Sarcoma-Associated,KSHV,Kaposi Sarcoma-Associated Herpesvirus,HHV-8,Herpesvirus, Kaposi's Sarcoma-Associated,Human Herpesvirus 8,Kaposi's Sarcoma-Associated Herpesvirus,Herpesvirus, Kaposi Sarcoma Associated,Herpesvirus, Kaposi's Sarcoma Associated,Herpesvirus, Kaposis Sarcoma-Associated,Herpesviruses, Kaposi's Sarcoma-Associated,Kaposi Sarcoma Associated Herpesvirus,Kaposi's Sarcoma Associated Herpesvirus,Kaposi's Sarcoma-Associated Herpesviruses,Kaposis Sarcoma-Associated Herpesvirus,Sarcoma-Associated Herpesvirus, Kaposi,Sarcoma-Associated Herpesviruses, Kaposi's

Related Publications

Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
A case of HHV-8-associated HIV-negative primary effusion lymphoma in Moscow.
March 2007, Journal of medical virology,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma: report of two cases.
January 2010, American journal of hematology,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
HHV-8-positive but EBV-negative primary effusion lymphoma.
November 2013, Blood,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis.
October 2003, Leukemia & lymphoma,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients.
May 2004, American journal of hematology,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
A rare case of HHV-8-positive/HIV-negative/EBV-negative primary effusion lymphoma in a renal transplant recipient.
April 2012, Cytopathology : official journal of the British Society for Clinical Cytology,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma with genotypic infidelity and c-MYC expression.
September 2014, Annals of hematology,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients.
March 2002, Leukemia & lymphoma,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient.
October 1999, The Journal of pathology,
Shuro Yoshida, and Shigeyoshi Makino, and Yasuhiro Sugio, and Akira Ueda
Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma.
September 2011, International journal of hematology,
Copied contents to your clipboard!